25
CROS NT Company Presentation www.crosnt.com

CROS NT Company Overview

  • Upload
    cros-nt

  • View
    150

  • Download
    0

Embed Size (px)

DESCRIPTION

Check out a company overview of CROS NT.

Citation preview

Page 1: CROS NT Company Overview

CROS NT Company Presentation

www.crosnt.com

Page 2: CROS NT Company Overview

Company Overview – PM HoldingCompany Overview – PM Holding

Dedicated company to satisfy IT needs in Pharma

Dedicated to recruitment and insourcing for Pharma

CRO Business, niche services in ST, DM, PhV, MW

Page 3: CROS NT Company Overview

Company Overview – CROS NTCompany Overview – CROS NT

Celebrating 21 years in business this year

Offices in UK, Italy, Germany; Consultants in the U.S.

ISO certified

Over 800 projects completed

Customers from pharma, biotech, medical device and academic sectors

Strategically partner with CROs based on clinical, geographic or therapeutic area needs

Strategic partnership with Arithmos to provide life science technology solutions

Page 4: CROS NT Company Overview

Company Overview – About UsCompany Overview – About UsCentre of Excellence for Clinical Trial Data: CROS NT has remained specialised in biometrics as more and more Sponsors are seeing the value in centralized data.

CROS NT also provides a Functional Service Provider (FSP) strategic outsourcing model which streamlines operations, accelerates timelines and cuts costs.

What we provide:

Page 5: CROS NT Company Overview

Dedicated to clinical data services (centre of excellence) with accompanying technologies

Services covering Protocol to CSR

Top talent and experience in providing statistical advice (FDA and EMA, DSMBs, Adaptive Design etc.)

Processes and technology that ensure excellent planning, management reporting and traceability of projects

Focus on standardization and minimization of costs

Overall achievement is higher quality at a lower price

100% customer retention

Less than 5% staff turnover

Obtaining ISO 22301- the world’s first international standard for Business Continuity Management

Company Overview - Why CROS NT?Company Overview - Why CROS NT?

Page 6: CROS NT Company Overview

TherapeuticArea Expertise

Page 7: CROS NT Company Overview

Therapeutic Area ExpertiseTherapeutic Area Expertise

CROS NT has completed over 800 clinical studies in a

variety of therapeutic areas, providing

statistical analysis and programming and data management services.

In addition to these therapeutic areas, we also have experience in immunology, neurology,

vaccines, CNS, ophthamology, gynaecology, metabolic diseases, rheumatology and

haematology.

Page 8: CROS NT Company Overview

Therapeutic Area Expertise – RespiratoryTherapeutic Area Expertise – Respiratory

Respiratory is a therapeutic area of expertise for CROS NT, given that we have completed approximately 100 studies in this area, on both single country and international level and in various clinical phases and post-market studies.

Page 9: CROS NT Company Overview

Therapeutic Area Expertise – Cardiovascular/CardiologyTherapeutic Area Expertise – Cardiovascular/Cardiology

We have conducted approximately 70

cardiology studies for some of the world’s

largest pharmaceutical companies. CROS NT has

performed data management, statistical

analysis and programming for cardiovascular studies in Phases I-IV as well as observational studies.

In a recent study for a large pharma company, CROS NT provided a biometrics package of DM,

STAT, PhV, and statistical consultancy support for the DSMB for a Phase II hypertension study run in

24 sites internationally.

Page 10: CROS NT Company Overview

Therapeutic Area Expertise – OncologyTherapeutic Area Expertise – Oncology

CROS NT has completed more than 70 clinical trials in multiple oncology indications from small Phase I trials to large Phase III-IV multinational trials. We have worked in a variety of indications including breast cancer, colorectal cancer, AML, lung cancer, lymphoma and leukemia.

Recent Examples

Study 1: 1,200 patients in 104 centres

Study 2: 3,754 patients in 135 centres

Study 3: 793 patients in 104 centres

Study 4: 3,642 patients in 138 centres

CROS NT is currently involved in 10 on-going oncology studies with 8 different Sponsors.

CROS NT has been working since 2009 on a breast cancer study for a large pharma company. It is a randomized, multi-centre study involving 4,173 randomized patients. We are also attending DMC meetings as independent statisticians.

Page 11: CROS NT Company Overview

Outline of Services

Page 12: CROS NT Company Overview

• Centralizing clinical data falls under the functional service provider outsourcing strategy. It has the potential to increase quality while reducing overall costs.

Problems Sponsors Face When Data Is Not Centralized

Solution: Benefits of Centralized Data

Lack of traceability of information Less risk

Difficult cross product analysis, unexplained conclusions when numerous companies handle

data

All data in one place: greater efficiency, consistent communication and reporting using

common assessment methods

Slow resolution of regulatory queries Improved response to regulatory obligations

Unfamiliar with Sponsor requirements Increased Value of Intellectual Property

Dispersed clinical data across a programme of studies

Reduced Costs

Strategic Outsourcing Approach: Centralization of DataStrategic Outsourcing Approach: Centralization of Data

Page 13: CROS NT Company Overview

• FSP: outsourcing model whereby CROS NT provides a scalable team of resources working from CROS NT offices with occasional site work

• Billing done monthly based on hours worked (rather than fixed pricing)

• Benefits:– Scalable team of experts in DM, Biostatistics, PhV, Medical Writing

– Continuity of trained resources

– Improved and accelerated timelines

– Control of overhead costs

– Consistent pricing

– Reduction in Sponsor Project Management time

– Lower recruitment/HR costs

13

Strategic Outsourcing: Functional Service Provider ModelStrategic Outsourcing: Functional Service Provider Model

Page 14: CROS NT Company Overview

14

Life Sciences Technology PortfolioLife Sciences Technology Portfolio

Symphony is a simple, low cost, web-based Electronic Data Capture (EDC) system for collecting, managing and reporting data from clinical trials.

Page 15: CROS NT Company Overview

15

Clinical Data ManagementClinical Data Management

CROS NT has acquired extensive knowledge through the management of vast amounts of data generated by clinical trials. This enables the DM team to improve speed, efficiency and cost effectiveness while conducting clinical trials.

An expert Data Management team can provide:

CRF Design & Review DB Design

Data Management Report Development Development and Programming of Data Validation Specifications

Data Management Plan Development External Data Providers Management

CRF Tracking Data Entry

Fax-Scanner Data Entry Medical Coding

Instream Data Review Discrepancy/Query Management

Database Quality Control EDC

Insourcing of Data Managers at Sponsor Site CDISC SDTM Compliant Databases

Page 16: CROS NT Company Overview

16

BiostatisticsBiostatistics

CROS NT has delivered expert statistical analyses across all phases of drug development and in a wide range of therapeutic areas for over 20 years. Each analysis is conducted using validated and standardized procedures in compliance with regulatory guidelines.

Our expert statistical methodology team can provide:

Blind Review: Planning, Meeting & Documentation

Randomization Management

Study Design Protocol Writing & Review

Sample Size Calculation Statistical Analysis Plan

Data Review Filing and Reporting for Regulatory Submission

Statistical Consultancy Integrated Summaries of Safety and Efficacy

Adaptive Trial Design + Bayesian Method

Page 17: CROS NT Company Overview

17

Statistical ProgrammingStatistical Programming

CROS NT maintains a highly qualified group of SAS programmers to provide excellent statistical analysis and reporting. We require 6 months of prior programming experience to become a CROS NT SAS programmer and a minimum of 2 years of experience to be a Senior SAS programmer.

Our expert team of statistical programmers can provide:Meta-analysis Data Listing

Statistical Reporting Presentation of Results

ISS/ISE pooled dataset creations CDISC Consultancy

Legacy data conversion to SDTM/ADaM Creation of SDTM/ADaM for ongoing studies

SDTM/ADaM Modelling Consultancy

Page 18: CROS NT Company Overview

18

CDISC ConsultancyCDISC Consultancy

CROS NT statisticians have training in CDISC standards and implementing SDTM and ADaM datasets. The statistical programming team can prepare ADaM datasets for both traceability and analysis-ready requirements.

CDISC related services include:

Taking customer defined standards and creating CDISC SDTM and ADaM datasets

Creation of documentation related to SDTM: SDTM annotated CRF, SDTM metadata,

DEFINE.PDF, DEFINE.XML

Creation of documentation related to ADaM: Analysis level, dataset level, variable level,

parameter level documentation

Mapping of studies from legacy to CDISC standards for ISS/ISE reporting and FDA

submission

Creation of documentation for integrated databases

Statistical programming for TFLs using ADaM derived datasets as input for the production of

statistical results

Page 19: CROS NT Company Overview

19

PharmacovigilancePharmacovigilance

CROS NT offers a case data entry, processing and reporting service for adverse events via a hosted safety database. It can also provide the installation & validation of Oracle AERS or Argus safety databases on customers’ servers.

Our expert pharmacovigilance team can provide:

Low cost Case Data Entry Periodic Reporting

Adverse Event Processing Expedited Reporting

Safety Narratives Set-up & Management of a Global Safety Database

EudraVigilance registration & reporting Risk Management Plans

Page 20: CROS NT Company Overview

20

Medical WritingMedical Writing

CROS NT has compiled an expert team of Medical Writers with decades of experience in both Europe and North America.

Our expert Medical Writing team can provide:

Clinical Study Reports Common Technical Documents (CTD/eCTDs)

EMA and FDA Briefing Packages Investigator Brochure

Statistical Analysis Plans (SAPs) Integrated Summaries (ISS/ISE)

PSUR/DSUR Posters

Abstracts

Page 21: CROS NT Company Overview

CROS NT has conducted over 500 studies that including statistical analysis and consultancy. In 2012, CROS NT created an independent consultancy department and named a Director of Consultancy Services to offer exclusive statistical consultancy services to pharmaceutical companies, including:

21

Statistical ConsultancyStatistical Consultancy

Complex Trial Design: Adaptive, Randomized, Blind

Bayesian Framework

Interim analyses DSMB Support

ISS/ISE Regulatory Submissions (FDA and EMA)

CDISC Standard Implementation Training Courses & Webinars

Page 22: CROS NT Company Overview

• Adaptive Trial Designs offer greater flexibility and the possibility to modify a study in progress such as: sample size, criteria for inclusion/exclusion, changes in doses or treatment regiment, study endpoints, and the possibility of early closure

• CROS NT’s expert statisticians can assist with following:

Work with sponors to improve the trial design Use simulations to calculate the power of the sample size and the

probability of success Define the decision rule for interim analyses and provide statistical

justification Provide EDC and reporting to efficiently manage data for interim

analyses

22

Statistical Consultancy – Adaptive Trial DesignStatistical Consultancy – Adaptive Trial Design

Page 23: CROS NT Company Overview

23

CROS Academy CROS Academy

Building off CROS NT's strong statistical heritage and expertise, CROS NT created CROS Academy which provides a series of webinars and on-site courses from top statisticians within the CROS NT organization as well as external consultants. 

Courses Planned for 2013:Introduction to Adaptive Trial Design (June 2013 in Italy, Germany, UK)Statistics Workshop (June 2013 in Switzerland)Biostatistics for Non-Statisticians: Understanding the Statistical Elements of a Study Protocol (September 2013)How to Read a Trial Publication (November 2013)

Page 24: CROS NT Company Overview

24

CROS CHECK – Web Portal for Data VisualizationCROS CHECK – Web Portal for Data Visualization

We offer a clinical data intelligence solution which includes a clinical research analytics tool – customizable to your reporting needs and functional with any system – to provide the most detailed reporting of structured and underlying data.

Page 25: CROS NT Company Overview

25

[email protected]

@CROS_NT

CROS NT Clinical Corner